ID   FER_HUMAN               Reviewed;         822 AA.
AC   P16591; B2RCR4;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2006, sequence version 2.
DT   05-OCT-2010, entry version 120.
DE   RecName: Full=Tyrosine-protein kinase Fer;
DE            EC=2.7.10.2;
DE   AltName: Full=Proto-oncogene c-Fer;
DE   AltName: Full=Tyrosine kinase 3;
DE   AltName: Full=p94-Fer;
GN   Name=FER; Synonyms=TYK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT VAL-439.
RX   MEDLINE=89261786; PubMed=2725517;
RA   Hao Q.-L., Heisterkamp N., Groffen J.;
RT   "Isolation and sequence analysis of a novel human tyrosine kinase
RT   gene.";
RL   Mol. Cell. Biol. 9:1587-1593(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 686-741.
RX   MEDLINE=94067791; PubMed=8247543;
RA   Lee S.-T., Strunk K.M., Spritz R.A.;
RT   "A survey of protein tyrosine kinase mRNAs expressed in normal human
RT   melanocytes.";
RL   Oncogene 8:3403-3410(1993).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   MEDLINE=90191712; PubMed=2156206;
RA   Krolewski J.J., Lee R., Eddy R., Shows T.B., Dalla-Favera R.;
RT   "Identification and chromosomal mapping of new human tyrosine kinase
RT   genes.";
RL   Oncogene 5:277-282(1990).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   MEDLINE=91117224; PubMed=1990274;
RA   Hao Q.-L., Ferris D.K., White G., Heisterkamp N., Groffen J.;
RT   "Nuclear and cytoplasmic location of the FER tyrosine kinase.";
RL   Mol. Cell. Biol. 11:1180-1183(1991).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-402 AND TYR-714, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-402; SER-434 AND
RP   TYR-714, AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-402, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=17389395; DOI=10.1073/pnas.0608638104;
RA   Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.;
RT   "Multiple reaction monitoring for robust quantitative proteomic
RT   analysis of cellular signaling networks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-402; SER-411; SER-434
RP   AND TYR-714, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-402; THR-410; SER-411;
RP   SER-434 AND TYR-714, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [12]
RP   VARIANT VAL-439.
RX   MEDLINE=91335211; PubMed=1651563; DOI=10.1126/science.1651563;
RA   Nishisho I., Nakamura Y., Miyoshi Y., Miki Y., Ando H., Horii A.,
RA   Koyama K., Utsunomiya J., Baba S., Hedge P., Markham A., Krush A.J.,
RA   Petersen G.M., Hamilton S.R., Nilbert M.C., Levy D.B., Bryan T.M.,
RA   Preisinger A.C., Smith K.J., Su L.-K., Kinzler K.W., Vogelstein B.;
RT   "Mutations of chromosome 5q21 genes in FAP and colorectal cancer
RT   patients.";
RL   Science 253:665-669(1991).
RN   [13]
RP   VARIANTS [LARGE SCALE ANALYSIS] PHE-128; GLN-404; VAL-412; VAL-439;
RP   PRO-443; CYS-460 AND GLN-813.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Tyrosine kinase of the non-receptor type. Probably
CC       performs an important function, perhaps in regulatory processes
CC       such as cell cycle control.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Associated with the
CC       chromatin.
CC   -!- TISSUE SPECIFICITY: Expressed in a variety of lymphoid cell lines.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Fes/fps subfamily.
CC   -!- SIMILARITY: Contains 1 FCH domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 SH2 domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J03358; AAA61190.1; -; mRNA.
DR   EMBL; AK315234; BAG37661.1; -; mRNA.
DR   EMBL; CH471086; EAW49055.1; -; Genomic_DNA.
DR   IPI; IPI00029263; -.
DR   PIR; A31943; TVHUFE.
DR   RefSeq; NP_005237.2; -.
DR   UniGene; Hs.221472; -.
DR   PDB; 2KK6; NMR; -; A=453-557.
DR   PDBsum; 2KK6; -.
DR   ProteinModelPortal; P16591; -.
DR   SMR; P16591; 1-281, 452-820.
DR   MINT; MINT-261636; -.
DR   STRING; P16591; -.
DR   PhosphoSite; P16591; -.
DR   PeptideAtlas; P16591; -.
DR   PRIDE; P16591; -.
DR   Ensembl; ENST00000281092; ENSP00000281092; ENSG00000151422.
DR   Ensembl; ENST00000438717; ENSP00000394297; ENSG00000151422.
DR   GeneID; 2241; -.
DR   KEGG; hsa:2241; -.
DR   UCSC; uc003kop.1; human.
DR   CTD; 2241; -.
DR   GeneCards; GC05P108111; -.
DR   H-InvDB; HIX0032042; -.
DR   HGNC; HGNC:3655; FER.
DR   HPA; CAB022464; -.
DR   HPA; HPA007641; -.
DR   MIM; 176942; gene.
DR   PharmGKB; PA28095; -.
DR   eggNOG; prNOG05339; -.
DR   HOGENOM; HBG446727; -.
DR   HOVERGEN; HBG005655; -.
DR   InParanoid; P16591; -.
DR   OMA; RHFIIQY; -.
DR   OrthoDB; EOG9FTZKZ; -.
DR   PhylomeDB; P16591; -.
DR   BRENDA; 2.7.10.2; 247.
DR   Pathway_Interaction_DB; fcer1pathway; Fc-epsilon receptor I signaling in mast cells.
DR   Pathway_Interaction_DB; pdgfrbpathway; PDGFR-beta signaling pathway.
DR   Pathway_Interaction_DB; ptp1bpathway; Signaling events mediated by PTP1B.
DR   Pathway_Interaction_DB; kitpathway; Signaling events mediated by Stem cell factor receptor (c-Kit).
DR   NextBio; 9065; -.
DR   ArrayExpress; P16591; -.
DR   Bgee; P16591; -.
DR   CleanEx; HS_FER; -.
DR   Genevestigator; P16591; -.
DR   GO; GO:0005737; C:cytoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kina...; IEA:EC.
DR   GO; GO:0023034; P:intracellular signaling pathway; TAS:ProtInc.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IEA:InterPro.
DR   InterPro; IPR001060; FCH.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR020764; Tyr_kinase_non-rcpt_Fes.
DR   InterPro; IPR016250; Tyr_kinase_non-rcpt_Fes_subgr.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   Gene3D; G3DSA:3.30.505.10; SH2; 1.
DR   PANTHER; PTHR23256:SF268; Tyr_kinase_non-rcpt_Fes; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   Pfam; PF00611; FCH; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00017; SH2; 1.
DR   PIRSF; PIRSF000632; TyrPK_fps; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00055; FCH; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50133; FCH; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Cytoplasm; Kinase;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Proto-oncogene; SH2 domain; Transferase; Tyrosine-protein kinase.
FT   CHAIN         1    822       Tyrosine-protein kinase Fer.
FT                                /FTId=PRO_0000088084.
FT   DOMAIN        1     58       FCH.
FT   DOMAIN      460    550       SH2.
FT   DOMAIN      563    816       Protein kinase.
FT   NP_BIND     569    577       ATP (By similarity).
FT   ACT_SITE    684    684       Proton acceptor (By similarity).
FT   BINDING     591    591       ATP (By similarity).
FT   MOD_RES     402    402       Phosphotyrosine.
FT   MOD_RES     410    410       Phosphothreonine.
FT   MOD_RES     411    411       Phosphoserine.
FT   MOD_RES     434    434       Phosphoserine.
FT   MOD_RES     714    714       Phosphotyrosine; by autocatalysis.
FT   VARIANT     128    128       V -> F (in dbSNP:rs35150210).
FT                                /FTId=VAR_041691.
FT   VARIANT     404    404       E -> Q (in an ovarian Endometrioid
FT                                carcinoma sample; somatic mutation).
FT                                /FTId=VAR_041692.
FT   VARIANT     412    412       M -> V (in dbSNP:rs33940843).
FT                                /FTId=VAR_041693.
FT   VARIANT     439    439       L -> V (in dbSNP:rs34499946).
FT                                /FTId=VAR_006282.
FT   VARIANT     443    443       A -> P (in dbSNP:rs34259824).
FT                                /FTId=VAR_041694.
FT   VARIANT     460    460       W -> C (in a lung small cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041695.
FT   VARIANT     507    507       I -> T (in dbSNP:rs34204308).
FT                                /FTId=VAR_051695.
FT   VARIANT     813    813       E -> Q (in dbSNP:rs56097357).
FT                                /FTId=VAR_041696.
FT   TURN        455    457
FT   HELIX       467    472
FT   STRAND      480    484
FT   STRAND      492    497
FT   STRAND      502    510
FT   STRAND      513    515
FT   HELIX       524    533
SQ   SEQUENCE   822 AA;  94638 MW;  BD42DF6C03419C76 CRC64;
     MGFGSDLKNS HEAVLKLQDW ELRLLETVKK FMALRIKSDK EYASTLQNLC NQVDKESTVQ
     MNYVSNVSKS WLLMIQQTEQ LSRIMKTHAE DLNSGPLHRL TMMIKDKQQV KKSYIGVHQQ
     IEAEMIKVTK TELEKLKCSY RQLIKEMNSA KEKYKEALAK GKETEKAKER YDKATMKLHM
     LHNQYVLALK GAQLHQNQYY DITLPLLLDS LQKMQEEMIK ALKGIFDEYS QITSLVTEEI
     VNVHKEIQMS VEQIDPSTEY NNFIDVHRTT AAKEQEIEFD TSLLEENENL QANEIMWNNL
     TAESLQVMLK TLAEELMQTQ QMLLNKEEAV LELEKRIEES SETCEKKSDI VLLLSQKQAL
     EELKQSVQQL RCTEAKFSAQ KELLEQKVQE NDGKEPPPVV NYEEDARSVT SMERKERLSK
     FESIRHSIAG IIRSPKSALG SSALSDMISI SEKPLAEQDW YHGAIPRIEA QELLKKQGDF
     LVRESHGKPG EYVLSVYSDG QRRHFIIQYV DNMYRFEGTG FSNIPQLIDH HYTTKQVITK
     KSGVVLLNPI PKDKKWILSH EDVILGELLG KGNFGEVYKG TLKDKTSVAV KTCKEDLPQE
     LKIKFLQEAK ILKQYDHPNI VKLIGVCTQR QPVYIIMELV SGGDFLTFLR RKKDELKLKQ
     LVKFSLDAAA GMLYLESKNC IHRDLAARNC LVGENNVLKI SDFGMSRQED GGVYSSSGLK
     QIPIKWTAPE ALNYGRYSSE SDVWSFGILL WETFSLGVCP YPGMTNQQAR EQVERGYRMS
     APQHCPEDIS KIMMKCWDYK PENRPKFSEL QKELTIIKRK LT
//
